Arsenic methylation capability, heme oxygenase-1 and NADPH quinone oxidoreductase-1 genetic polymorphisms and the stage and grade of urothelial carcinomas

Steven K. Huang, Wen-Hsiang Chiou, Yeong Shiau Pu, Yung-Kai Huang, Chi Jung Chung, Hui J. Tsai, Mo Hsiung Yang, Chien Jen Chen, Yu-Mei Hsueh

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: Arsenic exposure is associated with an increased risk of urothelial carcinoma (UC). To explore the distribution of the arsenic methylation capability in patients with different stages and grades of UCs, 100 UC cases were recruited between September 2002 and May 2004 for this study. Methods: Urinary arsenic species, including inorganic arsenic (AsIII + AsV), monomethylarsonic acid (MMA), and dimethylarsinic acid (DMA), were determined with a high-performance liquid chromatography-linked hydride generator and atomic absorption spectrometry. Determining the percentages of various arsenic species among the total urinary arsenic amount assessed the arsenic methylation capability. The primary methylation index (PMI) was defined as the ratio between MMA and inorganic arsenic. The secondary methylation index (SMI) was determined as the ratio between DMA and MMA. Results: Differential effects of the arsenic methylation capability were found among patients with different stages of UCs; however, none was found among different grades. Conclusion: A significantly different distribution of the HO-1 genotype was found in subjects with different-stage UCs; however, it was not related to the NAD(P)H:quinone oxidoreductase 1 genotype.

Original languageEnglish
Pages (from-to)405-412
Number of pages8
JournalUrologia Internationalis
Volume80
Issue number4
DOIs
Publication statusPublished - Jun 2008

Fingerprint

Heme Oxygenase-1
Arsenic
Genetic Polymorphisms
NADP
Methylation
Oxidoreductases
Carcinoma
Cacodylic Acid
Genotype
benzoquinone
NAD
Spectrum Analysis
High Pressure Liquid Chromatography

Keywords

  • Arsenic
  • Bladder neoplasms
  • Methylation

ASJC Scopus subject areas

  • Urology

Cite this

Arsenic methylation capability, heme oxygenase-1 and NADPH quinone oxidoreductase-1 genetic polymorphisms and the stage and grade of urothelial carcinomas. / Huang, Steven K.; Chiou, Wen-Hsiang; Pu, Yeong Shiau; Huang, Yung-Kai; Chung, Chi Jung; Tsai, Hui J.; Yang, Mo Hsiung; Chen, Chien Jen; Hsueh, Yu-Mei.

In: Urologia Internationalis, Vol. 80, No. 4, 06.2008, p. 405-412.

Research output: Contribution to journalArticle

Huang, Steven K. ; Chiou, Wen-Hsiang ; Pu, Yeong Shiau ; Huang, Yung-Kai ; Chung, Chi Jung ; Tsai, Hui J. ; Yang, Mo Hsiung ; Chen, Chien Jen ; Hsueh, Yu-Mei. / Arsenic methylation capability, heme oxygenase-1 and NADPH quinone oxidoreductase-1 genetic polymorphisms and the stage and grade of urothelial carcinomas. In: Urologia Internationalis. 2008 ; Vol. 80, No. 4. pp. 405-412.
@article{9364665571bc47a18ce26521efc302fe,
title = "Arsenic methylation capability, heme oxygenase-1 and NADPH quinone oxidoreductase-1 genetic polymorphisms and the stage and grade of urothelial carcinomas",
abstract = "Background: Arsenic exposure is associated with an increased risk of urothelial carcinoma (UC). To explore the distribution of the arsenic methylation capability in patients with different stages and grades of UCs, 100 UC cases were recruited between September 2002 and May 2004 for this study. Methods: Urinary arsenic species, including inorganic arsenic (AsIII + AsV), monomethylarsonic acid (MMA), and dimethylarsinic acid (DMA), were determined with a high-performance liquid chromatography-linked hydride generator and atomic absorption spectrometry. Determining the percentages of various arsenic species among the total urinary arsenic amount assessed the arsenic methylation capability. The primary methylation index (PMI) was defined as the ratio between MMA and inorganic arsenic. The secondary methylation index (SMI) was determined as the ratio between DMA and MMA. Results: Differential effects of the arsenic methylation capability were found among patients with different stages of UCs; however, none was found among different grades. Conclusion: A significantly different distribution of the HO-1 genotype was found in subjects with different-stage UCs; however, it was not related to the NAD(P)H:quinone oxidoreductase 1 genotype.",
keywords = "Arsenic, Bladder neoplasms, Methylation",
author = "Huang, {Steven K.} and Wen-Hsiang Chiou and Pu, {Yeong Shiau} and Yung-Kai Huang and Chung, {Chi Jung} and Tsai, {Hui J.} and Yang, {Mo Hsiung} and Chen, {Chien Jen} and Yu-Mei Hsueh",
year = "2008",
month = "6",
doi = "10.1159/000132699",
language = "English",
volume = "80",
pages = "405--412",
journal = "Urologia Internationalis",
issn = "0042-1138",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Arsenic methylation capability, heme oxygenase-1 and NADPH quinone oxidoreductase-1 genetic polymorphisms and the stage and grade of urothelial carcinomas

AU - Huang, Steven K.

AU - Chiou, Wen-Hsiang

AU - Pu, Yeong Shiau

AU - Huang, Yung-Kai

AU - Chung, Chi Jung

AU - Tsai, Hui J.

AU - Yang, Mo Hsiung

AU - Chen, Chien Jen

AU - Hsueh, Yu-Mei

PY - 2008/6

Y1 - 2008/6

N2 - Background: Arsenic exposure is associated with an increased risk of urothelial carcinoma (UC). To explore the distribution of the arsenic methylation capability in patients with different stages and grades of UCs, 100 UC cases were recruited between September 2002 and May 2004 for this study. Methods: Urinary arsenic species, including inorganic arsenic (AsIII + AsV), monomethylarsonic acid (MMA), and dimethylarsinic acid (DMA), were determined with a high-performance liquid chromatography-linked hydride generator and atomic absorption spectrometry. Determining the percentages of various arsenic species among the total urinary arsenic amount assessed the arsenic methylation capability. The primary methylation index (PMI) was defined as the ratio between MMA and inorganic arsenic. The secondary methylation index (SMI) was determined as the ratio between DMA and MMA. Results: Differential effects of the arsenic methylation capability were found among patients with different stages of UCs; however, none was found among different grades. Conclusion: A significantly different distribution of the HO-1 genotype was found in subjects with different-stage UCs; however, it was not related to the NAD(P)H:quinone oxidoreductase 1 genotype.

AB - Background: Arsenic exposure is associated with an increased risk of urothelial carcinoma (UC). To explore the distribution of the arsenic methylation capability in patients with different stages and grades of UCs, 100 UC cases were recruited between September 2002 and May 2004 for this study. Methods: Urinary arsenic species, including inorganic arsenic (AsIII + AsV), monomethylarsonic acid (MMA), and dimethylarsinic acid (DMA), were determined with a high-performance liquid chromatography-linked hydride generator and atomic absorption spectrometry. Determining the percentages of various arsenic species among the total urinary arsenic amount assessed the arsenic methylation capability. The primary methylation index (PMI) was defined as the ratio between MMA and inorganic arsenic. The secondary methylation index (SMI) was determined as the ratio between DMA and MMA. Results: Differential effects of the arsenic methylation capability were found among patients with different stages of UCs; however, none was found among different grades. Conclusion: A significantly different distribution of the HO-1 genotype was found in subjects with different-stage UCs; however, it was not related to the NAD(P)H:quinone oxidoreductase 1 genotype.

KW - Arsenic

KW - Bladder neoplasms

KW - Methylation

UR - http://www.scopus.com/inward/record.url?scp=46249134014&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46249134014&partnerID=8YFLogxK

U2 - 10.1159/000132699

DO - 10.1159/000132699

M3 - Article

C2 - 18587252

AN - SCOPUS:46249134014

VL - 80

SP - 405

EP - 412

JO - Urologia Internationalis

JF - Urologia Internationalis

SN - 0042-1138

IS - 4

ER -